Limoneira (NASDAQ:LMNR) Director Sells $186,484.48 in Stock

Limoneira (NASDAQ:LMNR) Director Donald R. Rudkin sold 11,648 shares of the firm’s stock in a transaction dated Tuesday, January 11th. The stock was sold at an average price of $16.01, for a total value of $186,484.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Shares of LMNR opened at $15.17 on Friday. The company has a current ratio of 1.19, a quick ratio of 0.95 and a debt-to-equity ratio of 0.69. Limoneira has a 12 month low of $14.16 and a 12 month high of $20.74. The stock’s 50 day moving average is $15.56 and its two-hundred day moving average is $16.24. The firm has a market cap of $268.51 million, a P/E ratio of -65.96, a PEG ratio of 3.42 and a beta of 1.03.

Limoneira (NASDAQ:LMNR) last issued its quarterly earnings data on Monday, January 10th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.02). Limoneira had a negative net margin of 2.07% and a negative return on equity of 1.77%. During the same period last year, the business earned ($0.42) earnings per share. Equities research analysts forecast that Limoneira will post 0.31 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 14th. Shareholders of record on Monday, December 27th were issued a $0.075 dividend. This is a positive change from Limoneira’s previous quarterly dividend of $0.05. This represents a $0.30 annualized dividend and a yield of 1.98%. The ex-dividend date was Thursday, December 23rd. Limoneira’s dividend payout ratio (DPR) is presently -130.43%.

Separately, Zacks Investment Research raised Limoneira from a “sell” rating to a “hold” rating in a report on Thursday. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Limoneira presently has an average rating of “Buy” and a consensus target price of $24.60.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp grew its holdings in Limoneira by 2.5% in the third quarter. Bank of New York Mellon Corp now owns 111,972 shares of the company’s stock valued at $1,811,000 after purchasing an additional 2,775 shares during the period. BNP Paribas Arbitrage SA grew its holdings in Limoneira by 421.8% in the third quarter. BNP Paribas Arbitrage SA now owns 3,835 shares of the company’s stock valued at $62,000 after purchasing an additional 3,100 shares during the period. Metropolitan Life Insurance Co NY acquired a new stake in Limoneira in the third quarter valued at approximately $74,000. Royal Bank of Canada grew its holdings in Limoneira by 2.8% in the third quarter. Royal Bank of Canada now owns 54,060 shares of the company’s stock valued at $875,000 after purchasing an additional 1,492 shares during the period. Finally, Invesco Ltd. boosted its stake in shares of Limoneira by 7.3% in the third quarter. Invesco Ltd. now owns 24,627 shares of the company’s stock worth $398,000 after acquiring an additional 1,682 shares during the last quarter. 47.80% of the stock is currently owned by institutional investors.

About Limoneira

Limoneira Co is an agribusiness and real estate development company, which engages in the innovation of agricultural citrus industry in California. It operates through the following three divisions: Agribusiness, Rental Operations, and Real Estate Development. The Agribusiness division is comprised of three operating segments: fresh lemons, lemon packing and other agribusiness, which includes avocados, oranges, specialty citrus and other crops.

Further Reading: What is the CBOE Russell 2000® Volatility Index?

Insider Buying and Selling by Quarter for Limoneira (NASDAQ:LMNR)

Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.